|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01358 PW MEDTECH
Nominal 
0.980 +0.015 (+1.554%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 394,056 | -4.903% | 823,505 | 768,903 | 675,084 | 536,826 |
| Cost of Sales | (204,153) | 1.269% | (416,046) | (349,455) | (294,187) | (238,001) |
| Gross Profit | 189,903 | -10.751% | 407,459 | 419,448 | 380,897 | 298,825 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | (127) | -60.436% | (1,820) | (1,182) | (61) | (250) | |
| Change in FV & Impairment on Others | 779 | -- | (1,220) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | (6,100) | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 50,828 | -50.710% | 164,994 | 229,753 | 231,067 | 157,747 | |
| Taxation | (13,146) | -20.337% | (29,741) | (37,231) | (26,044) | (28,880) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (22,990) | 11.494% | (40,879) | (41,742) | (51,839) | (22,826) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 14,692 | -77.739% | 94,374 | 150,780 | 153,184 | 106,041 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (14,636) | -36.151% | (42,694) | (50,272) | (43,671) | (34,904) |
| Depreciation & Amortisation | 73,437 | 7.380% | 139,858 | 117,746 | 98,261 | 78,586 |
| Directors' Emoluments | -- | -- | 2,219 | 2,217 | 2,205 | 2,127 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 1.010 | -77.252% | 6.250 | 9.770 | 9.780 | 6.770 |
| DPS (cts) | 0.951 | -- | 5.624 | 9.051 | 8.933 | 0.000 |
| Dividend Payout Ratio (%) | 94.188% | -- | 89.985% | 92.637% | 91.336% | -- |
| Cash flow per share ($) | -- | -- | 0.159 | 0.206 | 0.135 | 0.172 |
| NBV per share ($) | 2.695 | -- | 2.681 | 2.671 | 2.583 | 2.520 |
| Remarks: | Real time quote last updated: 09/09/2026 17:51 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 14,692 |
| %Change | -77.739% |
| EPS / (LPS) | RMB 0.010 |
| NBV Per Share (¥) | RMB 2.695 |